Jennifer Smith is the editor of Oncology Practice, part of MDedge Hematology/Oncology. She was previously the editor of Hematology Times, an editor at Principal Investigators Association, and a reporter at The Oneida Daily Dispatch. She has a BS in journalism.
News
Combo produces responses in triple-class refractory myeloma
Selinexor plus low-dose dexamethasone produced a response rate of 26% in patients who were refractory to at least one proteasome inhibitor, one...
News
New transfusion guidelines for thalassemia
Experts discussed recommendations for alpha and beta thalassemia as well as non–transfusion dependent thalassemia.
News
FDA approves fedratinib for myelofibrosis
Fedratinib is approved to treat adults with intermediate-2 or high-risk primary or secondary myelofibrosis.
News
Review reveals lack of data on mild hemophilia A
A review of 17 studies showed limited and inconsistent data on bleeding, joint pain, quality of life, and other outcomes.
Article
Cancer centers announce new faculty
New appointments at Georgia Cancer Center, Fox Chase, and the Oncology Institute of Hope and Innovation.
News
Transient opioid use linked to COPD exacerbation
Opioid exposure in the prior 7 days was associated with an 80.8% increase in the odds of exacerbation.
News
Timing, volume of transfusion may not matter in children with severe anemia
The TRACT trial showed no significant differences in 28-day mortality or other clinical outcomes by transfusion timing or volume.
Article
ASTRO announces new president-elect, board members
The new ASTRO president-elect plans to address physician burnout, restrictive prior authorization practices, and diversity in the workforce.
News
U.S. fertility rate, teen births are on the decline
The report from the Centers for Disease Control and Prevention also found an increase in vaginal births after previous cesarean delivery.
News
Results support first-line T-DM1 in HER2+ breast cancer
A phase 3 trial showed similar overall survival times in patients who received trastuzumab emtansine (T-DM1), T-DM1 plus pertuzumab, or...
News
BTK mutations linked to CLL progression on ibrutinib
The findings support mutational analysis in CLL patients on ibrutinib, according to researchers.
News
CAR T-cell therapy less effective in transformed follicular lymphoma
The complete response rate and duration of response were better in patients with follicular lymphoma than in those with transformed follicular...
News
Guidelines update donor selection criteria for HSCT
The evidence-based guidelines provide recommendations for selecting adult donors and cord blood units for allogeneic hematopoietic stem cell...
News
Large genetic cohort supports NfL as Alzheimer’s biomarker
LOS ANGELES – Mutation carriers in the world’s largest early onset AD cohort saw significant increases in neurofilament light (NfL) from age 22...
News
Test could inform care of patients with pancreatic cysts
The test, CompCyst, correctly identified 91% of patients who required surgery, 49% of those who required monitoring, and 60% of patients who...